Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;49(2):313-321.
doi: 10.4143/crt.2016.098. Epub 2016 Jul 7.

Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers

Affiliations

Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers

So Jeong Lee et al. Cancer Res Treat. 2017 Apr.

Abstract

Purpose: The prognostic significance of tumor-infiltrating lymphocytes (TILs) has been determined in breast cancers. Interferons can affect T-cell activity through direct and indirect mechanisms. Myxovirus resistance A (MxA) is an excellent marker of interferon activity. Here,we evaluated TILs and MxA expression in human epidermal growth factor receptor 2 (HER2)-positive breast cancers.

Materials and methods: Ninety cases of hormone receptor (HR)+/HER2+ tumors and 78 cases of HR-/HER2+ tumors were included. The TILs level was assessed using hematoxylin and eosin-stained full face sections, and MxA expressionwas evaluated by immunohistochemistrywith a tissue microarray.

Results: MxA protein expression was significantly higher in tumors with high histologic grade (p=0.023) and high levels of TILs (p=0.002). High levels of TILs were correlated with high histological grade (p=0.001), negative lymphovascular invasion (p=0.007), negative lymph node metastasis (p=0.007), absence of HR expression (p < 0.001), abundant tertiary lymphoid structures (TLSs) around ductal carcinoma in situ (p=0.018), and abundant TLSs around the invasive component (p < 0.001). High levels of TILs were also associated with improved disease-free survival, particularly in HR-/HER2+ breast cancers. However, MxA was not a prognostic factor.

Conclusion: High expression of MxA in tumor cells was associated with high levels of TILs in HER2-positive breast cancers. Additionally, a high level of TILs was a prognostic factor for breast cancer, whereas the level of MxA expression had no prognostic value.

Keywords: Breast neoplasms; Myxovirus resistance proteins; Tumor-infiltrating lymphocytes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest relevant to this article was not reported.

Figures

Fig. 1.
Fig. 1.
Evaluation of tumor infiltrating lymphocytes (TILs) level by histology with hematoxylin and eosin–stained sections according to the recommendation by the International TILs Working Group and tertiary lymphoid structures. Interpreted as 50% (A, ×100) and 70% (B, ×200) of TILs and tertiary lymphoid structure (C, ×200), a lymph-node like lymphoid accumulation showing high endothelial venule (arrowheads).
Fig. 2.
Fig. 2.
Expression of myxovirus resistance A (MxA) by immunohistochemistry: negative staining (A, ×400), weak staining (B, ×400), moderate staining (C, ×400), and strong staining (D, ×400) for MxA.
Fig. 3.
Fig. 3.
Relationship between tumor infiltrating lymphocytes (TILs) level and disease-free survival in total human epidermal growth factor receptor 2 (HER2)–positive breast cancers (A), hormone receptor (HR)+/HER2+ breast cancers (B), and HR–/HER2+ breast cancers (C).

References

    1. Ahn SG, Jeong J, Hong S, Jung WH. Current issues and clinical evidence in tumor-infiltrating lymphocytes in breast cancer. J Pathol Transl Med. 2015;49:355–63. - PMC - PubMed
    1. Stagg J, Loi S, Divisekera U, Ngiow SF, Duret H, Yagita H, et al. Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy. Proc Natl Acad Sci U S A. 2011;108:7142–7. - PMC - PubMed
    1. Lee HJ, Kim JY, Park IA, Song IH, Yu JH, Ahn JH, et al. Prognostic significance of tumor-infiltrating lymphocytes and the tertiary lymphoid structures in HER2-positive breast cancer treated with adjuvant trastuzumab. Am J Clin Pathol. 2015;144:278–88. - PubMed
    1. Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26:259–71. - PMC - PubMed
    1. Schlee M. Master sensors of pathogenic RNA: RIG-I like receptors. Immunobiology. 2013;218:1322–35. - PMC - PubMed

MeSH terms

LinkOut - more resources